LCRF funded researcher, James Welsh of The University of Texas MD Anderson Cancer Center, was part of novel research study that may lead to therapeutic strategies for the treatment of lung cancer in the future.
LUNGevity Foundation today announced a partnership with the Lung Cancer Research Foundation and Melanoma Research Alliance to co-fund new innovative research on PD-1 inhibitor treatment options for both non-small cell lung cancer (NSCLC) and metastatic melanoma (MM) patients with brain metastases.
Knowledge about the genetic mutations that cause tumors is offering the first real promise of drugs that can control lung cancer.
LCRF grant helps lung cancer research get one step closer to eliminating the disease.
The research from a study funded by LCRF in 2010 and 2011 was just published in the Journal of the National Cancer Institute. The study found that cells appearing normal may actually be harbingers of lung cancer. Join us in congratulating Humam Kadara, PHD on his work!
Sixteen Researchers Awarded $800,000 For Research During Month-Long Spotlight On Lung Cancer
Congratulations to Dr. Faye Johnson of the MD Anderson Cancer Center, the 2013 LCRF Scientific Merit Award Winner
LCRF is excited to support her pioneering work in non-small cell lung cancer.